OCT 27, 2026 · JOURNAL ARTICLE
GLP-1 receptor agonists and adverse outcomes in patients with type 2 diabetes and chronic viral hepatitis
Clinical and Molecular Hepatology
Background/Aims: Glucagon-like peptide-1 receptor agonists (GLP-1RA) are a novel class of anti-diabetic drugs that can treat obesity and type 2 diabetes (T2D). T2D and chronic vira